JENNIFER HAWKINS: Open Payments
NPI 1942049572 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,034 in 83 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $840 · 2025 $2,034
Food & beverage: $1,992Education: $43
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 37 | $747 |
| Madrigal Pharmaceuticals | 5 | $218 |
| Novo Nordisk Inc | 4 | $179 |
| Xeris Pharmaceuticals, Inc. | 10 | $175 |
| Corcept Therapeutics | 4 | $156 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Insulet Corporation | 4 | $67 |
| Radius Health, Inc. | 2 | $62 |
| Mannkind Corporation | 2 | $59 |
Products named: iLet Bionic Pancreas, REZDIFFRA, Ozempic, Korlym, GVOKE HYPOPEN, ISTURISA, Kerendia, Omnipod.
Industry payments across AZ — which companies pay providers there.
